sibenadet has been researched along with indacaterol in 3 studies
Studies (sibenadet) | Trials (sibenadet) | Recent Studies (post-2010) (sibenadet) | Studies (indacaterol) | Trials (indacaterol) | Recent Studies (post-2010) (indacaterol) |
---|---|---|---|---|---|
27 | 7 | 6 | 309 | 101 | 250 |
Protein | Taxonomy | sibenadet (IC50) | indacaterol (IC50) |
---|---|---|---|
Beta-1 adrenergic receptor | Homo sapiens (human) | 0.3162 | |
Beta-2 adrenergic receptor | Cavia porcellus (domestic guinea pig) | 0.0079 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 3 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Alcaraz, L; Bailey, A; Cadogan, E; Connolly, S; Dainty, I; Jewell, R; Jordan, S; Kindon, N; Lawson, M; Lister, A; Mullen, A; Nicholls, D; Paine, S; Pairaudeau, G; Stocks, MJ; Thorne, P; Young, A | 1 |
Beattie, D; Beer, D; Bradley, ME; Bruce, I; Charlton, SJ; Cuenoud, BM; Fairhurst, RA; Farr, D; Fozard, JR; Janus, D; Rosethorne, EM; Sandham, DA; Sykes, DA; Trifilieff, A; Turner, KL; Wissler, E | 1 |
Alcaraz, L; Bailey, A; Bonnert, R; Cadogan, E; Christie, J; Connolly, S; Cook, A; Dixon, J; Fisher, A; Flaherty, A; Humphries, A; Ingall, A; Jordan, S; Lawson, M; Mullen, A; Nicholls, D; Paine, S; Pairaudeau, G; Stocks, MJ; Young, A | 1 |
3 other study(ies) available for sibenadet and indacaterol
Article | Year |
---|---|
From libraries to candidate: the discovery of new ultra long-acting dibasic β₂-adrenoceptor agonists.
Topics: Adrenergic beta-Agonists; Animals; Asthma; Bronchodilator Agents; Cell Line, Tumor; Chemistry, Pharmaceutical; Cyclic AMP; Drug Design; Guinea Pigs; Humans; Inhibitory Concentration 50; Models, Chemical; Protein Binding; Pulmonary Disease, Chronic Obstructive; Thiazoles; Time Factors | 2012 |
An investigation into the structure-activity relationships associated with the systematic modification of the β(2)-adrenoceptor agonist indacaterol.
Topics: Adrenergic beta-2 Receptor Agonists; Dose-Response Relationship, Drug; Humans; Indans; Molecular Structure; Quinolones; Receptors, Adrenergic, beta-2; Structure-Activity Relationship | 2012 |
Discovery of AZD3199, An Inhaled Ultralong Acting β2 Receptor Agonist with Rapid Onset of Action.
Topics: | 2014 |